Latest Ratios: P/E Ratio -74.8x · EV/EBITDA 64.3x · ROE -2.5%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $196M | $91M | $105M | $160M | $112M | $136M | $67M | $62M | $64M | $89M | $48M |
| Enterprise Value | $198M | $93M | $111M | $132M | $121M | $142M | $64M | $59M | $46M | $76M | $19M |
| P/E Ratio → | -74.76 | — | 35.79 | 17.22 | 13.21 | 18.71 | — | 27.05 | 21.14 | 96.11 | 17.69 |
| P/S Ratio | 1.72 | 0.80 | 0.80 | 1.30 | 0.96 | 1.61 | 1.24 | 1.02 | 0.81 | 1.34 | 1.18 |
| P/B Ratio | 1.85 | 0.88 | 1.05 | 1.66 | 1.72 | 2.49 | 1.49 | 1.38 | 1.48 | 2.28 | 1.26 |
| P/FCF | 34.52 | 16.04 | 42.10 | 10.74 | — | 13.86 | 25.70 | — | 7.28 | 13.77 | 12.04 |
| P/OCF | 26.82 | 12.46 | 27.51 | 9.89 | — | 12.59 | 20.49 | — | 5.81 | 12.35 | 11.08 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.81 | 0.85 | 1.07 | 1.04 | 1.67 | 1.18 | 0.98 | 0.58 | 1.14 | 0.47 |
| EV / EBITDA | 64.32 | 30.12 | 12.60 | 8.76 | 7.83 | 12.24 | 32.47 | 23.27 | 6.49 | 14.13 | 3.99 |
| EV / EBIT | — | — | 25.89 | 11.29 | 11.22 | 16.72 | 934.59 | 21.27 | 3.79 | 7.19 | 4.56 |
| EV / FCF | — | 16.28 | 44.59 | 8.88 | — | 14.42 | 24.54 | — | 5.23 | 11.72 | 4.79 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.0% | 43.0% | 42.4% | 46.2% | 45.7% | 48.6% | 44.8% | 48.2% | 50.2% | 51.9% | 50.7% |
| Operating Margin | -3.3% | -3.3% | 2.6% | 8.5% | 9.2% | 10.0% | -2.3% | -1.1% | 6.6% | 5.4% | 10.3% |
| Net Profit Margin | -2.2% | -2.2% | 2.2% | 7.6% | 7.2% | 8.6% | -1.7% | 3.8% | 3.9% | 1.5% | 6.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -2.5% | -2.5% | 2.9% | 11.6% | 14.1% | 14.6% | -2.0% | 5.3% | 7.4% | 2.5% | 7.2% |
| ROA | -1.7% | -1.7% | 2.0% | 7.6% | 7.9% | 8.8% | -1.5% | 3.7% | 4.7% | 1.9% | 6.4% |
| ROIC | -2.6% | -2.6% | 2.9% | 11.0% | 12.0% | 12.4% | -2.2% | -1.4% | 15.2% | 15.4% | 32.1% |
| ROCE | -3.2% | -3.2% | 2.9% | 10.8% | 13.2% | 12.8% | -2.3% | -1.3% | 11.0% | 8.4% | 11.2% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.15 | 0.15 | 0.26 | 0.18 | 0.35 | 0.49 | 0.16 | 0.11 | — | — | — |
| Debt / EBITDA | 5.07 | 5.07 | 2.95 | 1.15 | 1.46 | 2.30 | 3.71 | 2.00 | — | — | — |
| Net Debt / Equity | — | 0.01 | 0.06 | -0.29 | 0.14 | 0.10 | -0.07 | -0.06 | -0.42 | -0.34 | -0.76 |
| Net Debt / EBITDA | 0.44 | 0.44 | 0.70 | -1.84 | 0.59 | 0.48 | -1.54 | -0.99 | -2.53 | -2.47 | -6.03 |
| Debt / FCF | — | 0.24 | 2.49 | -1.86 | — | 0.56 | -1.16 | — | -2.04 | -2.05 | -7.25 |
| Interest Coverage | -6.16 | -6.16 | 5.08 | 17.27 | 16.98 | 95.40 | — | — | 88.18 | — | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.20 | 2.20 | 2.47 | 3.53 | 2.23 | 2.08 | 3.04 | 2.98 | 1.66 | 2.15 | 7.52 |
| Quick Ratio | 1.32 | 1.32 | 1.63 | 2.70 | 1.40 | 1.56 | 2.20 | 2.12 | 1.36 | 1.81 | 6.79 |
| Cash Ratio | 0.40 | 0.40 | 0.62 | 1.86 | 0.50 | 0.85 | 1.16 | 0.91 | 0.83 | 0.92 | 5.66 |
| Asset Turnover | — | 0.75 | 0.86 | 0.91 | 1.06 | 0.82 | 0.87 | 1.02 | 1.17 | 1.07 | 0.94 |
| Inventory Turnover | 2.06 | 2.06 | 2.80 | 3.30 | 2.81 | 3.39 | 3.98 | 4.38 | 6.01 | 6.47 | 5.40 |
| Days Sales Outstanding | — | 83.02 | 82.38 | 53.80 | 66.28 | 71.11 | 57.20 | 55.94 | 49.08 | 66.47 | 48.79 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 2.8% | 5.8% | 7.6% | 5.3% | — | 3.7% | 4.7% | 1.0% | 5.7% |
| FCF Yield | 2.9% | 6.2% | 2.4% | 9.3% | — | 7.2% | 3.9% | — | 13.7% | 7.3% | 8.3% |
| Buyback Yield | 0.0% | 0.0% | 1.0% | 0.0% | 0.0% | 0.0% | 0.1% | 1.8% | 0.0% | 0.1% | 2.1% |
| Total Shareholder Yield | 0.0% | 0.0% | 1.0% | 0.0% | 0.0% | 0.0% | 0.1% | 1.8% | 0.0% | 0.1% | 2.1% |
| Shares Outstanding | — | $12M | $12M | $12M | $11M | $11M | $10M | $10M | $10M | $10M | $10M |
Cyclical Revenue Volatility
Based on reported financial data, inTEST's forward P/E of 34.78 suggests that market participants are pricing in a significant recovery in earnings, despite the company's recent TTM P/E of -77.29, which highlights the extreme sensitivity of its valuation to current cyclical troughs in semiconductor capital expenditure.
The wide disparity between trailing and forward multiples indicates that investors are looking past current operating losses, likely anticipating a rebound in demand for specialized testing hardware. However, given the lack of a PEG ratio and the volatility in historical earnings, this valuation appears highly speculative and contingent on a rapid return to profitability that may not materialize if industry utilization rates remain depressed.
As reported in quarterly filings, the company's ROIC has struggled to maintain positive territory, recently dipping to 1.2% in 2026Q1, which suggests that the firm is currently failing to generate returns on invested capital that exceed its likely cost of capital during this cyclical contraction.
The decay in ROIC from previous periods reflects the difficulty of maintaining efficient capital utilization when revenue volumes decline and fixed costs remain elevated. Investors should monitor whether management can improve asset turnover, which has remained stagnant around 0.22, or if the current capital base is simply too large for the current revenue environment.
According to recent financial statements, the company's cash conversion cycle has remained elevated at 177 days in 2026Q1, primarily driven by high inventory days of 151, which indicates significant inefficiencies in managing working capital relative to the current pace of semiconductor equipment demand.
The persistent length of the cash conversion cycle suggests that inTEST is carrying substantial inventory, potentially due to the custom-engineered nature of its products or a buildup of components that are not moving as quickly as anticipated. This lack of agility in working capital management exacerbates the company's liquidity constraints during periods of revenue volatility.
Based on the company's reported figures, the debt-to-equity ratio of 0.16 remains low, yet the interest coverage ratio has fluctuated wildly, reaching 11.93 in 2026Q1, which suggests that while the firm is not over-leveraged, its ability to service debt is highly sensitive to operating income volatility.
While the low debt load provides a buffer against insolvency, the company's reliance on operating cash flow to fund ongoing operations makes the interest coverage ratio a volatile metric that warrants close monitoring. The firm appears to be managing its balance sheet conservatively, but this does not fully insulate it from the cash flow pressures caused by cyclical revenue declines.
The P/E ratio is frequently misapplied to inTEST's business model, as it obscures the impact of non-recurring acquisition costs and cyclical operating leverage that distort net income, making EV/EBITDA a more reliable metric for assessing the company's underlying operational earning power throughout the semiconductor cycle.
Because inTEST operates as a custom hardware manufacturer with significant fixed costs, net income is often artificially depressed by amortization and cyclical overhead, rendering P/E ratios misleading. Analysts should instead focus on EV/EBITDA to normalize for capital structure and non-cash charges, providing a clearer view of the company's ability to generate cash from its core industrial operations.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying INTT stock.
inTEST Corporation's current P/E ratio is -74.8x. The historical average is 21.5x.
inTEST Corporation's current EV/EBITDA is 64.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 10.3x.
inTEST Corporation's return on equity (ROE) is -2.5%. The historical average is 6.8%.
Based on historical data, inTEST Corporation is trading at a P/E of -74.8x. Compare with industry peers and growth rates for a complete picture.
inTEST Corporation has 43.0% gross margin and -3.3% operating margin.
inTEST Corporation's Debt/EBITDA ratio is 5.1x, indicating high leverage. A ratio above 4x may signal elevated financial risk.